Brief: Coherus BioSciences Q2 EPS USD -0.11
08/08/2024 21:05
Aug 08 (Reuters) - Coherus BioSciences Q2 net income USD -12.921 million. * Q2 adjusted net income USD -16.441 million * Q2 pretax profit USD -12.921 million vs. IBES estimate USD -19.2 million * Q2 sales USD 64.979 million vs. IBES estimate USD 61.4 million * Q2 operating income USD -20.509 million vs. IBES estimate USD -19.1 million
Recent news on Coherus Oncology
See all newsBrief: Coherus Oncology Initiates Process To Sell Legacy Biosim Assets
Brief: Coherus Oncology Announces Special Dividend Of Biosimilar Contingent Value Rights
Coherus Oncology Inc reports results for the quarter ended June 30 - Earnings Summary
Coherus Oncology Q2 revenue rises 40% on higher LOQTORZI volume, but slightly falls below estimates
Brief: Coherus Oncology Q2 Net Income USD -20.631 Million